New Delhi: The US Embassy in New Delhi announced on September 18, 2025, that it has revoked and denied visas for certain Indian business executives and their family members due to alleged involvement in trafficking fentanyl precursors. The action is part of the Trump administration’s efforts to combat synthetic narcotics. The identities of the affected individuals were not disclosed.

Key Details

  • Legal Basis: The visa revocations were made under various sections of the US Immigration and Nationality Act.

  • Scope: The affected individuals and their close family members may be ineligible for future travel to the United States.

  • Future Implications: Executives linked to companies known to have trafficked fentanyl precursors will face heightened scrutiny in future visa applications.

    • Official Statement

    US Embassy Chargé d’Affaires Jorgan Andrews emphasized the embassy’s commitment to combating illicit drug trafficking, stating that individuals and organizations involved in the illegal production and trafficking of drugs to the United States, along with their families, will face consequences, including potential denial of access to the United States.